Have a feature idea you'd love to see implemented?
Let us know!
MBIO Mustang Bio Inc
Price (delayed)
$0.2079
Market cap
$9.93M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.56
Enterprise value
$7.02M
Mustang Bio, Inc. ("Mustang") is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare
Highlights
MBIO's EPS has surged by 80% year-on-year and by 43% since the previous quarter
MBIO's net income has surged by 63% year-on-year and by 27% since the previous quarter
The quick ratio has shrunk by 62% YoY and by 18% QoQ
MBIO's equity is down by 3.9% since the previous quarter
Key stats
What are the main financial stats of MBIO
Market
Valuations
Earnings
Shares outstanding
47.78M
Market cap
$9.93M
Enterprise value
$7.02M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$23.42M
EBITDA
-$22.3M
Free cash flow
-$16.7M
Per share
Balance sheet
Liquidity
EPS
-$1.56
Free cash flow per share
-$0.45
Book value per share
-$0.23
Revenue per share
$0
TBVPS
$0.2
Total assets
$7.19M
Total liabilities
$15.85M
Debt
$983,000
Equity
-$8.66M
Working capital
-$8.98M
Debt to equity
-0.11
Current ratio
0.4
Quick ratio
0.28
Net debt/EBITDA
0.13
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-194.9%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MBIO stock price
How has the Mustang Bio stock price performed over time
Intraday
-0.53%
1 week
-11.79%
1 month
-29.17%
1 year
-86.41%
YTD
-84.6%
QTD
-11.64%
Financial performance
How have Mustang Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$23.97M
Net income
-$23.42M
Gross margin
N/A
Net margin
N/A
MBIO's net income has surged by 63% year-on-year and by 27% since the previous quarter
MBIO's operating income has soared by 60% YoY and by 27% from the previous quarter
Growth
What is Mustang Bio's growth rate over time
Valuation
What is Mustang Bio stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
MBIO's EPS has surged by 80% year-on-year and by 43% since the previous quarter
MBIO's equity is down by 3.9% since the previous quarter
Efficiency
How efficient is Mustang Bio business performance
MBIO's ROA has plunged by 68% YoY but it is up by 7% from the previous quarter
Dividends
What is MBIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for MBIO.
Financial health
How did Mustang Bio financials performed over time
Mustang Bio's total assets is 55% less than its total liabilities
Mustang Bio's total assets has plunged by 65% YoY and by 16% from the previous quarter
The quick ratio has shrunk by 62% YoY and by 18% QoQ
The company's debt is 111% higher than its equity
The debt to equity has shrunk by 117% YoY but it rose by 15% QoQ
The company's debt has shrunk by 62% YoY and by 9% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.